Klein Matthew B. sold 16,000 shares of ClearPoint Neuro, Inc. at $11.59 for −$185k on May 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$185,440Shares × reported price
Shares traded
16,000Common Stock
Price per share
$11.59Reported price. Read footnotes for ranges.
% of reported position traded
25.42%This security and ownership context
Holdings after
46,935Direct
Trade date
May 21, 2026Sell
Filed
May 26, 2026, 4:30 PM ET5-day reporting delay
Accession
0001193125-26-239431Code S · Transaction 384894
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 62,935 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Grant12,820$0.00$0Trade 384895
2 transaction rows in this filing. Joint filers share the same rows.

CLPT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLPT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −9.3%1w ago +8%1d ago −5.2%
Returns since7d +4.7%30d +52%90d +28%180d1y

Footnotes in full

F1: Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.57 to $11.65. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F2: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F3: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.